Timeline
2019
2020
- Langen Junior Science Award
- WHO Declares Pandemic
- Paul Ehrlich and Ludwig Darmstaedter Prize
- Supply Bottleneck for Pneumococcal Vaccines
- Blood Donation Remains Possible
- Convalescent Plasma: First Clinical Trial
- COVID-19 Vaccines: First Clinical Trial
- Marketing Authorisation of Gene Therapy
- COVID-19 Vaccines: Second Clinical Trial Approved
- German Presidency of the EU Council
- COVID-19 Vaccines: Two Clinical Trials Approved
- Another Clinical Trial Approved
- Start of Two Rolling Review Procedures
- Allergen Products: European Standards
- Allergen Product: First European Marketing Authorisation
- COVID-19 Peptide Vaccine: First Clinical Trial
- COVID-19 Vaccine: Third Rolling Review Procedure
- Validation of COVID-19 Rapid Tests
- First Marketing Authorisation of a COVID-19 Vaccine
- SafeVac App Available
On 15 July 1994, the then Federal Minister of Health Horst Seehofer published the “Ordinance on the Introduction of Official Batch Testing of Blood Preparations” in the Federal Law Gazette. In the same year, Seehofer transferred responsibility for blood and blood products to the Paul-Ehrlich-Institut. These measures were a consequence of the HIV scandal in the 1990s, when thousands of people with haemophilia became infected with HIV. Today, blood and blood products in Germany are among the safest in the world, thanks in part to the Paul-Ehrlich-Institut.